We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

179 hedge funds and large institutions have $198M invested in SANGAMO THERAPEUTICS INC in 2023 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 75 increasing their positions, 40 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more call options, than puts

Call options by funds: $248K | Put options by funds: $110K

88% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 40

3.16% more ownership

Funds ownership: 63.44% → 66.6% (+3.2%)

4% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 23

2% less funds holding

Funds holding: 182 → 179 (-3)

37% less capital invested

Capital invested by funds: $315M → $198M (-$118M)

Holders
179
Holders Change
-3
Holders Change %
-1.65%
% of All Funds
2.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
75
Reduced
40
Closed
23
Calls
$248K
Puts
$110K
Net Calls
+$138K
Net Calls Change
-$404K

Top Buyers

Rank Fund Capital Flow
1
RCMU
Rokos Capital Management (UK)
United Kingdom
+$9.84M
2
Citadel Advisors
Citadel Advisors
Florida
+$5.22M
3
Renaissance Technologies
Renaissance Technologies
New York
+$3.18M
4
ECM
ExodusPoint Capital Management
New York
+$3.11M
5
WA
Wasatch Advisors
Utah
+$2.83M

Top Sellers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
-$5.56M
2
State Street
State Street
Massachusetts
-$2.36M
3
LOAMS
Lombard Odier Asset Management (Switzerland)
Switzerland
-$1.91M
4
RPAM
Rhenman & Partners Asset Management
Sweden
-$1.44M
5
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$1.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Assenagon Asset Management
26
Assenagon Asset Management
Luxembourg
$1.59M +$112K +39,107 +5%
Qube Research & Technologies (QRT)
27
Qube Research & Technologies (QRT)
United Kingdom
$1.48M +$1.77M +620,577 +281%
Rafferty Asset Management
28
Rafferty Asset Management
New York
$1.16M -$239K -83,888 -11%
Nordea Investment Management
29
Nordea Investment Management
Sweden
$1.11M -$94.3K -33,052 -5%
Citigroup
30
Citigroup
New York
$1.08M +$784K +274,818 +81%
Mirae Asset Global Investments
31
Mirae Asset Global Investments
South Korea
$924K +$79.8K +27,974 +6%
Jacobs Levy Equity Management
32
Jacobs Levy Equity Management
New Jersey
$919K +$1.15M +404,467 +344%
Wells Fargo
33
Wells Fargo
California
$905K +$325K +113,905 +28%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$880K +$5.7K +1,998 +0.4%
HF
35
HRT Financial
New York
$852K +$1.38M +484,151 New
Acadian Asset Management
36
Acadian Asset Management
Massachusetts
$822K +$1.34M +468,239 New
Macquarie Group
37
Macquarie Group
Australia
$704K – – –
Barclays
38
Barclays
United Kingdom
$667K -$341K -119,448 -24%
Tudor Investment Corp
39
Tudor Investment Corp
Connecticut
$640K -$33.2K -11,648 -3%
Federated Hermes
40
Federated Hermes
Pennsylvania
$563K +$509K +178,507 +126%
Millennium Management
41
Millennium Management
New York
$543K +$275K +96,324 +45%
RPAM
42
Rhenman & Partners Asset Management
Sweden
$534K -$1.44M -505,843 -62%
Swiss National Bank
43
Swiss National Bank
Switzerland
$529K -$58.8K -20,600 -6%
William Blair & Company
44
William Blair & Company
Illinois
$519K – – –
CANY
45
Caxton Associates (New York)
New York
$507K +$351K +123,145 +75%
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$498K +$381K +133,352 +89%
UBS Group
47
UBS Group
Switzerland
$471K -$926K -324,441 -55%
Ohio Public Employees Retirement System (OPERS)
48
Ohio Public Employees Retirement System (OPERS)
Ohio
$457K +$23.5K +8,225 +3%
BNP Paribas Financial Markets
49
BNP Paribas Financial Markets
France
$455K +$302K +105,748 +69%
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
$418K -$48.9K -17,143 -7%
1
2
3 4 5

SGMO Hedge Fund Activity: Q1 2023 in Review

179 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q1 2023, worth a combined $198M — down 37% from $315M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of SGMO and 22 opened new positions — a net loss of 1 holder — while 40 trimmed existing stakes and 75 added.

The largest buyer was Rokos Capital Management (UK), adding an estimated $9.84M. The largest seller was Nuveen, cutting an estimated $5.56M.

  • 179 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q1 2023, down from 182 in Q4 2022.
  • Funds reported $198M of SANGAMO THERAPEUTICS INC stock for Q1 2023, down 37% quarter-over-quarter.
  • 22 funds opened new SANGAMO THERAPEUTICS INC positions in Q1 2023 and 23 closed out, a net change of -1 holder.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q1 2023 was Rokos Capital Management (UK), an estimated $9.84M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q1 2023 was Nuveen, an estimated $5.56M sold.

Based on aggregated 13F filings for Q1 2023.